Disturbances in dental development after total body irradiation in bone marrow transplant recipients. 1988

G Dahllöf, and M Barr, and P Bolme, and T Modéer, and B Lönnqvist, and O Ringdén, and A Heimdahl
Department of Pedodontics, Huddinge Hospital, Karolinska Institute, Stockholm, Sweden.

The dental status of 16 children who had been treated with bone marrow transplantation (BMT) for serious bone marrow diseases was followed for up to 6 years. Several types of disturbances in dental development were observed in children who had been conditioned with total body irradiation (TBI) at 10 Gy before BMT. Thus, impaired root development that caused short V-shaped roots was found in all patients, a complete failure of root development and premature apical closure were found in five patients, enamel hypoplasia was observed in four patients, and microdontia was observed in three patients conditioned with TBI. Patients younger than 6 years of age at BMT exhibited the most severe and extensive dental aberrations. The TBI at 10 Gy appeared to be the major cause of the disturbances found.

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D009805 Odontogenesis The process of TOOTH formation. It is divided into several stages including: the dental lamina stage, the bud stage, the cap stage, and the bell stage. Odontogenesis includes the production of tooth enamel (AMELOGENESIS), dentin (DENTINOGENESIS), and dental cementum (CEMENTOGENESIS). Odontogeneses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D003730 Dental Care for Disabled Dental care for the emotionally, mentally, or physically disabled patient. It does not include dental care for the chronically ill ( Dental Care for Handicapped,Dentistry for Disabled,Dentistry for Handicapped,Disabled, Dentistry for,Handicapped, Dentistry for
D003744 Dental Enamel Hypoplasia An acquired or hereditary condition due to deficiency in the formation of tooth enamel (AMELOGENESIS). It is usually characterized by defective, thin, or malformed DENTAL ENAMEL. Risk factors for enamel hypoplasia include gene mutations, nutritional deficiencies, diseases, and environmental factors. Enamel Hypoplasia,Enamel Agenesis,Enamel Hypoplasia, Dental,Hypoplasia, Dental Enamel,Hypoplastic Enamel,Agenesis, Enamel,Enamel Ageneses,Enamel Hypoplasias,Enamel, Hypoplastic,Hypoplasia, Enamel
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Dahllöf, and M Barr, and P Bolme, and T Modéer, and B Lönnqvist, and O Ringdén, and A Heimdahl
December 1996, Japanese journal of clinical oncology,
G Dahllöf, and M Barr, and P Bolme, and T Modéer, and B Lönnqvist, and O Ringdén, and A Heimdahl
February 1991, Scandinavian journal of dental research,
G Dahllöf, and M Barr, and P Bolme, and T Modéer, and B Lönnqvist, and O Ringdén, and A Heimdahl
October 1986, La Radiologia medica,
G Dahllöf, and M Barr, and P Bolme, and T Modéer, and B Lönnqvist, and O Ringdén, and A Heimdahl
January 1991, European journal of clinical pharmacology,
G Dahllöf, and M Barr, and P Bolme, and T Modéer, and B Lönnqvist, and O Ringdén, and A Heimdahl
March 1995, Acta paediatrica (Oslo, Norway : 1992),
G Dahllöf, and M Barr, and P Bolme, and T Modéer, and B Lönnqvist, and O Ringdén, and A Heimdahl
December 1990, International journal of radiation oncology, biology, physics,
G Dahllöf, and M Barr, and P Bolme, and T Modéer, and B Lönnqvist, and O Ringdén, and A Heimdahl
March 1989, International journal of radiation oncology, biology, physics,
G Dahllöf, and M Barr, and P Bolme, and T Modéer, and B Lönnqvist, and O Ringdén, and A Heimdahl
June 1985, British journal of haematology,
G Dahllöf, and M Barr, and P Bolme, and T Modéer, and B Lönnqvist, and O Ringdén, and A Heimdahl
June 1979, Pathologie-biologie,
G Dahllöf, and M Barr, and P Bolme, and T Modéer, and B Lönnqvist, and O Ringdén, and A Heimdahl
February 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Copied contents to your clipboard!